Brief: Probi And Örebro University To Collaborate On Research Into Exploration Of Novel, Needle Free Vaccines
July 2 (Reuters) - Probi AB PROB.ST :
* PROBI AND ÖREBRO UNIVERSITY TO COLLABORATE ON RESEARCH
INTO
EXPLORATION OF NOVEL, NEEDLE FREE VACCINES
* ÖREBRO UNIVERSITY, IN COLLABORATION WITH PROBI AB, AND
NINE
OTHER SWEDISH COMPANIES HAVE BEEN GRANTED FUNDING FOR RESEARCH
INTO NOVEL, NEEDLE FREE VACCINES THROUGH DELIVERY VIA MUCOUS
MEMBRANES INSTEAD OF USING TRADITIONAL INJECTIONS
Source text for Eikon: ID:nWkr8jKRlD
Further company coverage: PROB.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Probi AB
See all newsBrief: Probi To Delist, Last Trading Day Is Feb 12, 2025
Brief: Probi Applies For Delisting And Convenes An Extraordinary General Meeting
Brief: Probi Says Independent Bid Committee Of Co Recommends Shareholders To Accept Cash-Based Public Takeover Offer Submitted By Symrise AG
Probi shares surge in line with premium after Symrise buyout offer
Brief: Symrise Announces Public Offer To Shareholders Of Probi To Tender All Shares